News 15.03.21

Glycostem enters into Material Transfer Agreement with Pieris to enhance solid tumor targeting capabilities of Glycostem’s oNKord® and CAR-NK treatments

Under the terms of the agreement, Pieris will provide Glycostem with Anticalin constructs against immune targets to be combined with Glycostem’s oNKord® technology to study the combined potential of the technologies in the treatment of solid tumors.

Read more
News 02.03.21

The Netherlands is putting its mark on the map of innovative pharmacy

Innovation within the pharmaceutical sector. This topic was discussed more than ever in 2020-2021.

Read more
News 01.03.21

ELF paper selected for print in a special issue of SLAS Discovery

European Lead Factory: Experiences and Output from Assay Development and Ultra-High-Throughput Screening.

Read more
News 01.03.21

Pivot Park Partner of TU/e Contest

Pivot Park is a proud partner of the TU/e Contest.

Read more
News 25.02.21

PharmSupport and the HAN developed a post-graduate course

Pivot Park gaat intensief samenwerken met de Hogeschool van Arnhem en Nijmegen (HAN).

Read more
News 25.02.21

Radboud Summer School at Pivot Park

Pivot Park gaat intensief samenwerken met de Hogeschool van Arnhem en Nijmegen (HAN).

Read more
News 06.01.21

TRIAS nieuwe sponsor LifetecZONe

Met ingang van dit jaar is subsidieadviesbureau TRIAS de nieuwe sponsor van LifetecZONe.

Read more
News 04.01.21

2020 highlights Pivot Park Community

Read here a short summary of the 2020 highlights of our Community members

Read more
News 04.01.21

AdaptVac partners with BioConnection to manufacture their COVID-19 vaccine

BioConnection announces that it is collaborating with AdaptVac for the Drug Product manufacture of their COVID-19 vaccine.

Read more